Our newest board company, AstraZeneca has appointed Richard Buckley, Vice President of North America Corporate Affairs as the MBRT board of directors representative.
Buckley is responsible for U.S. federal and state government affairs for AstraZeneca, as well as: public policy; corporate, product, and employee communications; corporate responsibility; ally development; and community relations. He has dotted-line responsibility for Canada Corporate Affairs, overseeing the alignment of global best practices and talent management, and strategic continuity with Corporate Affairs globally. He serves on both the U.S. Leadership Team and the Global Corporate Affairs Leadership Team for AstraZeneca.
“It is a privilege to welcome Rich Buckley to MBRT’s Board of Directors,” said Brian Dulay, MBRT Executive Director. “The combination of Mr. Buckley’s experience in the life sciences sector and his company’s sustained commitment to education will benefit MBRT as we work to serve the needs of students in Maryland.”
“AstraZeneca and MedImmune are excited to join MBRT in their advocacy for education reform, student achievement and workforce preparedness in Maryland,” Mr. Buckley said. “As a major life sciences employer in the state, it’s vital that we have a strong local workforce to draw from in the future and MBRT’s STEM education programs are essential to fulfilling this need. I look forward to joining my peers on the board.”